论文信息 - Positive Short-Term Effect of Low-Dose Rosuvastatin in a Patient with SYNGAP1-Associated Epilepsy

Positive Short-Term Effect of Low-Dose Rosuvastatin in a Patient with SYNGAP1-Associated Epilepsy

1Clinic for Neuropediatrics and Neurological Rehabilitation, Epilepsy Center for Children and Adolescents, Schön Klinik Vogtareuth, Vogtareuth, Germany 2Research Institute for Rehabilitation, Transition and Palliation, PMU Salzburg, Austria 3Comprehensive Epilepsy Program for Children, Division of Pediatric Neurology, DevelopmentalMedicine and Social Pediatrics, Department of Pediatrics, University Hospital Munich, Munich, Germany 4Epilepsy Unit for Adult Patients, Schön Klinik Vogtareuth, Vogtareuth, Germany

S. Arnold | G. Kluger | T. Hartlieb | K. Eschermann | Celina von Stülpnagel-Steinbeis

[1] G. Rumbaugh,et al. Species-conserved SYNGAP1 phenotypes associated with neurodevelopmental disorders , 2018, Molecular and Cellular Neuroscience.

[2] S. Grant,et al. Chronic treatment with a MEK inhibitor reverses enhanced excitatory field potentials in Syngap1^+/− mice , 2018, Pharmacological reports : PR.

[3] C. Funke,et al. SYNGAP1 Mutation in Focal and Generalized Epilepsy: A Literature Overview and A Case Report with Special Aspects of the EEG , 2015, Neuropediatrics.

[4] A. Constanti,et al. Statins and epilepsy: preclinical studies, clinical trials and statin-anticonvulsant drug interactions. , 2015, Current drug targets.

[5] E. Kılıç,et al. HMG-CoA reductase inhibitor rosuvastatin improves abnormal brain electrical activity via mechanisms involving eNOS , 2015, Neuroscience.

[6] J. Zhu,et al. Ras and Rap Signaling in Synaptic Plasticity and Mental Disorders , 2011, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[7] A. Reiss,et al. Statins in Neurological Disorders: Mechanisms and Therapeutic Value , 2009, TheScientificWorldJournal.